Estimates Revisions OSE Immunotherapeutics Deutsche Boerse AG
Stocks
6OP
FR0012127173
Biotechnology & Medical Research
|
Market Closed -
Deutsche Boerse AG
09:01:38 25/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 2.410 EUR | -4.74% |
|
-6.73% | -54.01% |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Data source:
OSE Immunotherapeutics(OSE)
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Data source:
OSE Immunotherapeutics(OSE)
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| - | |||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
Data source:
OSE Immunotherapeutics(OSE)
EBIT
Dividend / Share (DPS)
Data source:
OSE Immunotherapeutics(OSE)
Cash or Net Debt
- Stock Market
- Stocks
- OSE Stock
- 6OP Stock
- Consensus OSE Immunotherapeutics
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
